RIPK1 Antibody

1. The caspase 8 mediated RIPK1 cleavage product has a pro-apoptotic function, and further cleavage of this pro-apoptotic cleavage product by human rhinovirus 3C protease may provide a mechanism by which human rhinovirus limits apoptosis. PMID:29371673
2. The major function of RIP1 kinase activity in TNF-induced necroptosis is to autophosphorylate serine 161. This specific phosphorylation then enables RIP1 to recruit RIP3 and form a functional necrosome, a central controller of necroptosis. PMID:28176780
3. In lesional psoriatic epidermis, RIPK1-expression was decreased compared with that in normal epidermis. RIPK1-knockdown enhanced TRAIL-mediated expression of psoriasis-relating cytokines in normal human epidermal keratinocytes. PMID:29661487
4. RIPK1 plays a critical role in the human immune system. PMID:30026316
5. Elevated A20 promotes TNF-induced and RIPK1-dependent intestinal epithelial cell death PMID:30209212
6. RIPK1-DD has a role in mediating RIPK1 dimerization and activation of its kinase activity during necroptosis and RIPK1-dependent apoptosis PMID:29440439
7. We further identified this underlying mechanism also involved a PPARgamma-induced ANXA1-dependent autoubiquitination of cIAP1, the direct E3 ligase of RIP1, shifting cIAP1 toward proteosomal degradation..our study provides first insight for the suitability of using drug-induced expression of ANXA1 as a new player in RIP1-induced death machinery in triple-negative breast cancer PMID:29021293
8. data suggest that artesunate could induce RIP1-dependent cell death in human renal carcinoma. PMID:28466458
9. RIP1 has a role in CD40-mediated activation of caspase-8, which in turn leads to induction of apoptosis PMID:28610909
10. High RIPK1 expression is associated with Alzheimer's disease. PMID:28904096
11. These data represent the first report of decreased RIPK1 expression in neutrophils of Systemic Lupus Erythematosus patients and imply that RIPK1 may be involved in neutrophil death and neutrophil extracellular traps formation. PMID:29550813
12. Data indicate that receptor (TNFRSF)-interacting serine-threonine kinase 1 (RIPK1) polymorphism is a prognostic biomarker for tumor development and survival of hepatocellular carcinoma (HCC) patients after hepatectomy. PMID:28759952
13. Existence of a kinase-independent role of nuclear RIPK1 in the regulation of PARP1. PMID:28993228
14. Study identify and quantify over 8,000 phosphorylated peptides, among which are numerous known sites in the TNF-RSC, NFkappaB, and MAP kinase signaling systems. Functional analysis of S320 phosphorylation in RIPK1 demonstrates a role for this event in suppressing its kinase activity, association with CASPASE-8 and FADD proteins, and subsequent necrotic cell death during inflammatory TNFalpha stimulation. PMID:28539327
15. New potent RIPK1 inhibitors are reported (GSK2606414 and GSK2656157). PMID:28452996
16. the in vivo effects were diametrically reversed with RIP3 deletion or RIP1 blockade, resulting in marked tumor protection. The dichotomy between the in vivo and in vitro results suggests that the microenvironmental milieu resulting from RIP1/RIP3 signaling is likely responsible for its protumorigenic effects PMID:27932417
17. Shikonin induces glioma cell necroptosis in vitro by reactive oxygen species overproduction and promoting RIP1/RIP3 necrosome formation. PMID:28816233
18. the cytoplasmic retinoic acid receptor gamma (RARgamma) controls receptor-interacting protein kinase 1 (RIP1)-initiated cell death when cellular inhibitor of apoptosis (cIAP) activity is blocked. PMID:28871172
19. SIRT2 and RIPK1 were localized to the syncytiotrophoblast, villous leukocytes and vasculature in all preterm placentas. A significant reduction in SIRT2 protein expression in both preeclampsia and fetal growth restricted placentas was identified. RIPK1 mRNA expression was significantly increased in preeclampsia placentas. Immunofluorescence identified both SIRT2 and RIPK1 in the cytotrophoblast cytoplasm. PMID:28292463
20. Results show that downregulation of RIP1 results in increased resistance to SN38, implying a requirement for RIP1 in mediating cytotoxicity through the TNF/TNFR signaling pathway. PMID:28087739
21. Renal clear cell carcinoma cells cells express increased amounts of RIPK1 and RIPK3 and are poised to undergo necroptosis in response to TNFR1 signaling. PMID:27362805
22. Data suggest that pro-death signals through TIR-domain-containing adapter-inducing interferon-beta (TRIF) are regulated by autophagy and propose that pro-apoptotic signalling through TRIF/RIPK1/caspase-8 occurs in fibrillary platforms. PMID:28453927
23. UL45 promoted the UL48-RIP1 interaction and re-localization of RIP1 to the UL48-containing virion assembly complex. PMID:28570668
24. we provide evidence that p62 is implicated in the activation of NF-kappaB signaling that is partly dependent on RIP1 PMID:28498503
25. inactivation of RIP1/RIP3 resulted in reduction of SOCS1 protein levels and partial differentiation of AML cells. AML cells with inactivated RIP1/RIP3 signaling show increased sensitivity to IFN-gamma-induced differentiation. PMID:27748372
26. Data show that pan-caspase inhibitors facilitated 5-fluorouracil (5-FU)-induced necroptosis mediated by secretion of tumor necrosis factor alpha (TNF-alpha) driven by nuclear factor kappaB (NF-kappaB) and required RIP1 kinase. PMID:26522725
27. RIPK1 kinase activity is a pertinent therapeutic target to protect liver against excessive cell death in liver diseases. PMID:27831558
28. Ripk1 is directly involved in apoptosis/necroptosis. In osteosarcoma cells( OS) , small interfering RNA against Ripk1 prevented cell death induced by the sequestration of miR-155-5p. Collectively, we show that miR-148a-3p and miR-155-5p are species-conserved deregulated miRNA in OS PMID:27041566
29. RIPK1 collaborates with TRAF2 to inhibit murine and human hepatocarcinogenesis. PMID:28017612
30. Necroptosis signaling is modulated by the kinase RIPK1 and requires the kinase RIPK3 and the pseudokinase MLKL. (Review) PMID:26865533
31. CYLD Promotes TNF-alpha-Induced Cell Necrosis Mediated by RIP-1 in Human Lung Cancer Cells PMID:27738385
32. TRAIL can enhance RIP1 and c-FLIPL expression in HepG2 cells. PMID:28270653
33. Data indicate that RIP-1 promote the growth and invasion of gastric cancer in vitro and in vivo, additionally providing evidence that targeting RIP-1 may be useful in the treatment of gastric cancer. PMID:27035122
34. High expression of RIP1 is associated with hepatocellular carcinoma. PMID:27699664
35. The main route of cell death induced by shikonin is RIP1K-RIP3K-mediated necroptosis. PMID:26496737
36. Upregulated expression of RIP1 is associated with triple-negative breast cancer. PMID:27476169
37. Innate immune signaling through differential RIPK1 expression promote tumor progression in head and neck squamous cell carcinoma. PMID:26992898
38. Positive significant correlation was found for RIP1K expression. PMID:26749282
39. Hyperglycemic Conditions Prime Cells for RIP1-dependent Necroptosis. PMID:27129772
40. In contrast, both necrostatin-1, a RIP1 kinase inhibitor, and Enbrel, a TNFalpha-blocking antibody, do not interfere with BV6/Drozitumab-induced apoptosis, demonstrating that apoptosis occurs independently of RIP1 kinase activity or an autocrine TNFalpha loop. PMID:25880091
41. Report role of RIP1 in Smac mimetic mediated chemosensitization of neuroblastoma cells. PMID:26575016
42. By promoting both inflammation and cell death, RIPK1 may be a common mediator of axonal pathology in amyotrophic lateral sclerosis. PMID:27493188
43. Down-regulating RIP1 promotes oxaliplatin induced Tca8113 cells apoptosis PMID:26460489
44. RIPK1 and RIPK2 are targets of HIV-1 Protease activity during infection, and their inactivation may contribute to modulation of cell death and host defense pathways by HIV-1 PMID:26297639
45. These results identify upregulation of RIPK1 as an important resistance mechanism of melanoma cells to tunicamycin- or thapsigargin-induced endoplasmic reticulum stress. PMID:26018731
46. CD40 ligand induces RIP1-dependent, necroptosis-like cell death in low-grade serous but not serous borderline ovarian tumor cells. PMID:26313915
47. Data show that toll-like receptor 3/TRIF protein signalling regulates cytokines IL-32 and IFN-beta secretion by activation of receptor-interacting protein-1 (RIP-1) and tumour necrosis factor receptor-associated factor 6 (TRAF6) in cornea epithelial cells. PMID:25754842
48. in the absence of caspase-8 activity, 24(S)-Hydroxycholesterol induces a necroptosis-like cell death which is RIPK1-dependent but MLKL-independent. PMID:25697054
49. These data demonstrate that RIP1 is essential for the regulation of death receptor mediated autophagy and apoptosis. PMID:25583602
50. a novel non-enzymatic function of AChE-R is to stimulate RIPK1/MLKL-dependent regulated necrosis (necroptosis). The latter complements a cholinergic system in the ovary, which determines life and death of ovarian cells. PMID:25766324

Show More

Hide All

HGNC: 10019

UNIGENE: Hs.519842

KEGG: hsa:8737

STRING: 9606.ENSP00000259808

OMIM: 603453